Topics

Quant HC Company Profile

08:12 EDT 21st September 2019 | BioPortfolio

Quant HC is a predictive analytics medtech company based in Chicago, Illinois. It has partnered with Phillips Healthcare, Agile MD, Apervita, and others to offer its predictive algorithms to hospitals throughout the world. More information about Quant HC can be found at www.quanthc.com.


News Articles [5 Associated News Articles listed on BioPortfolio]

Hologic receives two CE marks for Aptima HIV-1 Quant Dx assay

With the procurement of CE marks, the assay is qualified to use in qualitatively detecting HIV-1 RNA in the diagnosis of HIV-1 infected infants under 18 months old, The post Hologic receives two CE m...

European regulators grant CE mark to Hologic's dual-claim HIV assay

Hologic has received CE mark certification for its Aptima HIV-1 Quant Dx assay for use in qualitative diagnosis of HIV-1 infe -More- 

Hologic’s Aptima HIV-1 Quant Dx Assay Receives Two CE Marks, Making It the First and Only Dual-Claim Assay for Both Viral Load and Early Infant Diagnosis

Hologic, Inc. (Nasdaq: HOLX) announced today that its Aptima® HIV-1 Quant Dx Assay has received two new CE marks in Europe – for early infant diagnosis (EID) and for testing dr...

Quantabio Ignites Superior NGS Library Prep Performance with Faster Workflows and More Affordable Costs at AGBT 2019

Company to showcase sparQ NGS portfolio, including solutions for DNA fragmentation, library preparation, high-fidelity amplification, purification/size selection, and library quan...

SCIEX Celebrates 30th Anniversary of API III and Unveils Innovations at ASMS 2019

New technology innovations mark the company’s next milestones, and build on its pioneering history SCIEX, a global leader in life science analytical technologies, rec...

Drugs and Medications [0 Results]

None

PubMed Articles [4 Associated PubMed Articles listed on BioPortfolio]

Objective measurement of forward-scattered light in the human eye: An electrophysiological approach.

Psychophysical measurements are used to examine the perception of ocular stray light, for example, with C-Quant. These measurements are subjective due to their principles. This work aims to determine ...

Performance evaluation of the Hologic Aptima HCV Quant Dx assay for detection of HCV RNA from dried blood spots.

The availability of effective direct-acting antiviral therapy for hepatitis C virus (HCV) has led to a need for simplified diagnostic pathways. Barriers to treatment uptake, specifically in people who...

TF-Test Quantified: A New Technique for Diagnosis of Schistosoma mansoni Eggs.

Laboratory diagnosis of Schistosoma mansoni eggs is routinely performed by conventional quantitative techniques through the parasitological examination of human feces. However, the diagnostic sensitiv...

Hybrid SWATH/MS and HR-SRM/MS acquisition for phospholipidomics using QUAL/QUANT data processing.

A hybrid SWATH/MS and HR-SRM/MS acquisition approach using multiple unit mass windows and 100 u precursor selection windows has been developed to interface with a chromatographic lipid class separatio...

Clinical Trials [4 Associated Clinical Trials listed on BioPortfolio]

Collection of Samples for the Clinical Evaluation of the Aptima HBV (Hepatitis B Virus) Quant (Quantification) Assay

This non-interventional clinical study will be conducted to prospectively collect serial plasma samples from subjects with chronic HBV infection who are initiating antiviral therapy. These...

Evaluation DBS for HCV RNA Testing

FIND is preparing a study to evaluate the performance, as measured by sensitivity and specificity, of three centralized assays for the detection of HCV RNA using capillary blood collected ...

Collection of Plasma and Serum Samples From Individuals Initiating Sofosbuvir for Chronic Hepatitis C for Testing

This non-interventional clinical study will be conducted to prospectively collect serial plasma and serum samples from treatment naïve subjects with chronic HCV infection who are initiati...

Detection and Quant of Differences in Hodgkin Lymphoma and Diffuse Large B-cell Lymphoma Using Positron Emission Tomography/Computed Tomography (PET/CT)

RATIONALE: Imaging procedures, such as positron emission tomography or computed tomography, may help in detecting differences between Hodgkin lymphoma or diffuse large B-cell lymphoma canc...

Companies [4 Associated Companies listed on BioPortfolio]

Quant HC

Quant HC is a predictive analytics medtech company based in Chicago, Illinois. It has partnered with Phillips Healthcare, Agile MD, Apervita, and others to offer its predictive al...

Bio-Quant, Inc

Bio-Quant is a profitable revenue-generating biotechnology company located in San Diego, California. The Company is engaged in development of natural product compounds for treatment of rare cancers an...

Apricus Biosciences, Inc.

Backed by NexMed, USA and Bio-Quant, Inc., its revenue generating CRO business, Apricus Bio has leveraged the flexibility of its proven NexACT® drug delivery technology to enab...

Apricus Biosciences

Backed by NexMed, USA and Bio-Quant, Inc., its revenue generating CRO business, Apricus Bio has leveraged the flexibility of its proven NexACT® drug delivery technology to enab...

More Information about "Quant HC" on BioPortfolio

We have published hundreds of Quant HC news stories on BioPortfolio along with dozens of Quant HC Clinical Trials and PubMed Articles about Quant HC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Quant HC Companies in our database. You can also find out about relevant Quant HC Drugs and Medications on this site too.

Quick Search

Relevant Topic

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...


Corporate Database Quicklinks



Searches Linking to this Company Record